DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Bladder cancer	R-HSA-9700206	map05219	maprotiline	4011	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	chlormezanone	2717	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	chlormezanone	2717	drug-path
Olfactory transduction	R-HSA-9751605	map04740	chlormezanone	2717	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	chlormezanone	2717	drug-path
Allograft rejection	R-HSA-9679028	map05330	chlormezanone	2717	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	chlormezanone	2717	drug-path
Alzheimer's disease	R-HSA-1643685	0	chlormezanone	2717	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	chlormezanone	2717	drug-path
Non-homologous end-joining	R-HSA-5693571	map03450	chlormezanone	2717	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	chlormezanone	2717	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	retrorsine	5281743	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	retrorsine	5281743	drug-path
Olfactory transduction	R-HSA-9751605	map04740	retrorsine	5281743	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	retrorsine	5281743	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	retrorsine	5281743	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	rescinnamine	4912	drug-path
Ubiquitin mediated proteolysis	R-HSA-983153	map04120	rescinnamine	4912	drug-path
Olfactory transduction	R-HSA-9751605	map04740	rescinnamine	4912	drug-path
Parkinson's disease	R-HSA-1643685	0	rescinnamine	4912	drug-path